Selected research
Industry Research
Sitagliptin Industry Research Report 2026
Market perspective
The global Sitagliptin market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Sitagliptin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Sitagliptin is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Sitagliptin is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Sitagliptin include Yonta, Baoling Pharma, Merck, De Xiang Pharmaceutical&Chemicals, Haikang Pharma and Phebra, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Sitagliptin market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Sitagliptin Market by Company
Yonta
Baoling Pharma
Merck
De Xiang Pharmaceutical&Chemicals
Haikang Pharma
Phebra
Sitagliptin Segment by Type
Injection
Tablets
Sitagliptin Segment by Application
Diabetes
Epilepsy
Others
Sitagliptin Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sitagliptin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sitagliptin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sitagliptin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Sitagliptin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Sitagliptin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Sitagliptin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injection
- Tablets
Applications
- Diabetes
- Epilepsy
- Others
Companies covered
- Yonta
- Baoling Pharma
- Merck
- De Xiang Pharmaceutical&Chemicals
- Haikang Pharma
- Phebra
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Sitagliptin Market Size (2021-2032)
- 2.2.2 Global Sitagliptin Sales (2021-2032)
- 2.2.3 Global Sitagliptin Market Average Price (2021-2032)
- 2.3 Sitagliptin by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Injection
- 2.3.3 Tablets
- 2.4 Sitagliptin by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Diabetes
- 2.4.3 Epilepsy
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Sitagliptin Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Sitagliptin Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Sitagliptin Revenue of Manufacturers (2021-2026)
- 3.4 Global Sitagliptin Average Price by Manufacturers (2021-2026)
- 3.5 Global Sitagliptin Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Sitagliptin, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Sitagliptin, Product Type & Application
- 3.8 Global Manufacturers of Sitagliptin, Established Date
- 3.9 Global Sitagliptin Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Yonta
- 4.1.1 Yonta Company Information
- 4.1.2 Yonta Business Overview
- 4.1.3 Yonta Sitagliptin Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Yonta Sitagliptin Product Portfolio
- 4.1.5 Yonta Recent Developments
- 4.2 Baoling Pharma
- 4.2.1 Baoling Pharma Company Information
- 4.2.2 Baoling Pharma Business Overview
- 4.2.3 Baoling Pharma Sitagliptin Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Baoling Pharma Sitagliptin Product Portfolio
- 4.2.5 Baoling Pharma Recent Developments
- 4.3 Merck
- 4.3.1 Merck Company Information
- 4.3.2 Merck Business Overview
- 4.3.3 Merck Sitagliptin Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Merck Sitagliptin Product Portfolio
- 4.3.5 Merck Recent Developments
- 4.4 De Xiang Pharmaceutical&Chemicals
- 4.4.1 De Xiang Pharmaceutical&Chemicals Company Information
- 4.4.2 De Xiang Pharmaceutical&Chemicals Business Overview
- 4.4.3 De Xiang Pharmaceutical&Chemicals Sitagliptin Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 De Xiang Pharmaceutical&Chemicals Sitagliptin Product Portfolio
- 4.4.5 De Xiang Pharmaceutical&Chemicals Recent Developments
- 4.5 Haikang Pharma
- 4.5.1 Haikang Pharma Company Information
- 4.5.2 Haikang Pharma Business Overview
- 4.5.3 Haikang Pharma Sitagliptin Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Haikang Pharma Sitagliptin Product Portfolio
- 4.5.5 Haikang Pharma Recent Developments
- 4.6 Phebra
- 4.6.1 Phebra Company Information
- 4.6.2 Phebra Business Overview
- 4.6.3 Phebra Sitagliptin Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Phebra Sitagliptin Product Portfolio
- 4.6.5 Phebra Recent Developments
5 Global Sitagliptin Market Scenario by Region
- 5.1 Global Sitagliptin Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Sitagliptin Sales by Region: 2021-2032
- 5.2.1 Global Sitagliptin Sales by Region: 2021-2026
- 5.2.2 Global Sitagliptin Sales by Region: 2027-2032
- 5.3 Global Sitagliptin Revenue by Region: 2021-2032
- 5.3.1 Global Sitagliptin Revenue by Region: 2021-2026
- 5.3.2 Global Sitagliptin Revenue by Region: 2027-2032
- 5.4 North America Sitagliptin Market Facts & Figures by Country
- 5.4.1 North America Sitagliptin Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Sitagliptin Sales by Country (2021-2032)
- 5.4.3 North America Sitagliptin Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Sitagliptin Market Facts & Figures by Country
- 5.5.1 Europe Sitagliptin Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Sitagliptin Sales by Country (2021-2032)
- 5.5.3 Europe Sitagliptin Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Sitagliptin Market Facts & Figures by Country
- 5.6.1 Asia Pacific Sitagliptin Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Sitagliptin Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Sitagliptin Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Sitagliptin Market Facts & Figures by Country
- 5.7.1 South America Sitagliptin Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Sitagliptin Sales by Country (2021-2032)
- 5.7.3 South America Sitagliptin Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Sitagliptin Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Sitagliptin Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Sitagliptin Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Sitagliptin Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Sitagliptin Sales by Type (2021-2032)
- 6.1.1 Global Sitagliptin Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Sitagliptin Sales Market Share by Type (2021-2032)
- 6.2 Global Sitagliptin Revenue by Type (2021-2032)
- 6.2.1 Global Sitagliptin Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Sitagliptin Revenue Market Share by Type (2021-2032)
- 6.3 Global Sitagliptin Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Sitagliptin Sales by Application (2021-2032)
- 7.1.1 Global Sitagliptin Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Sitagliptin Sales Market Share by Application (2021-2032)
- 7.2 Global Sitagliptin Revenue by Application (2021-2032)
- 7.2.1 Global Sitagliptin Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Sitagliptin Revenue Market Share by Application (2021-2032)
- 7.3 Global Sitagliptin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Sitagliptin Value Chain Analysis
- 8.1.1 Sitagliptin Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Sitagliptin Production Mode & Process
- 8.2 Sitagliptin Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Sitagliptin Distributors
- 8.2.3 Sitagliptin Customers
9 Global Sitagliptin Analyzing Market Dynamics
- 9.1 Sitagliptin Industry Trends
- 9.2 Sitagliptin Industry Drivers
- 9.3 Sitagliptin Industry Opportunities and Challenges
- 9.4 Sitagliptin Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst